Irritable Bowel Syndrome News

The three subtypes of irritable bowel syndrome did not significantly differ in terms of symptom severity and quality of life, according to recent study data.

Sigma-Tau Pharmaceuticals has announced a nationwide rollout of pharmacy shelf cards to better position its VSL#3 probiotics to make them more visible to consumers, according to a press release.

People with Giardia infections appear to have an increased risk for irritable bowel syndrome and chronic fatigue lasting as long as 6 years after the infection, according to data published in Clinical Infectious Diseases.

The American College of Gastroenterology has published an updated systematic review of data for the management of irritable bowel syndrome and chronic idiopathic constipation.

Fecal lactoferrin as a diagnostic biomarker effectively distinguished between inflammatory bowel disease and irritable bowel syndrome in a recent study.

Antidepressants and various psychological therapies effectively treated symptoms of irritable bowel syndrome in a recent study.

Sacral nerve stimulation therapy had no detectable effect on gastric emptying or small intestinal motility in patients with diarrhea-predominant or mixed irritable bowel syndrome, according to recent study data.

Linaclotide, a guanylate cyclase-C agonist, improved symptoms, quality of life and global measures in irritable bowel syndrome patients with constipation and severe abdominal symptoms in two recent clinical trials.

Ramosetron improved stool consistency, overall irritable bowel syndrome symptoms and quality of life in men who were IBS-diarrhea predominant, according to recent study data.

Patients with irritable bowel syndrome, primarily those who were nonconstipated, had elevated levels of colonic bile acid that was indicative of abnormal 75Se-labeled homocholic acid-taurine retention and high 7 alpha-hydroxy-4-cholesten-3-one serum levels in a recent study.